Home/Smart Money/Defilade Capital Management, L.P.
§ 13F · FUND PROFILE

Defilade Capital Management, L.P..

AUM · $747M (13F)Positions · 39Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$388M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 14, 2026
#TickerNameShares$ value% portΔ Q2
1LLYELI LILLY & CO39K$47M6.3%+89%
2PFEPFIZER INC1.77M$43M5.7%+21%
3VEEVVEEVA SYS INC237K$42M5.6%NEW
4BMRNBIOMARIN PHARMACEUTICAL INC682K$39M5.2%NEW
5PTCTPTC THERAPEUTICS INC434K$35M4.7%+15%
6BAXBAXTER INTL INC1.46M$31M4.2%NEW
7INSMINSMED INC282K$30M4.0%+45%
8ZBHZIMMER BIOMET HOLDINGS INC317K$27M3.7%−45%
9PODDINSULET CORP177K$27M3.6%NEW
10TMOTHERMO FISHER SCIENTIFIC INC52K$26M3.5%NEW
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE DEFILADE SIGNAL

AC read

Defilade Capital Management, L.P. is a Other fund managing $747 million in assets. The fund runs a portfolio of 39 positions.

Read the full dossier →